BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23617468)

  • 1. Pharmacotherapy of amphetamine-type stimulant dependence: an update.
    Brensilver M; Heinzerling KG; Shoptaw S
    Drug Alcohol Rev; 2013 Sep; 32(5):449-60. PubMed ID: 23617468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for amphetamine dependence: A systematic review.
    Lee NK; Jenner L; Harney A; Cameron J
    Drug Alcohol Depend; 2018 Oct; 191():309-337. PubMed ID: 30173086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of methamphetamine addiction: an update.
    Elkashef A; Vocci F; Hanson G; White J; Wickes W; Tiihonen J
    Subst Abus; 2008; 29(3):31-49. PubMed ID: 19042205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine Use: A New Wave in the Opioid Crisis?
    Fogger SA
    J Addict Nurs; 2019; 30(3):219-223. PubMed ID: 31478970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for methamphetamine abuse: a literature review for the clinician.
    Brackins T; Brahm NC; Kissack JC
    J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups.
    Soares E; Pereira FC
    Expert Opin Pharmacother; 2019 Dec; 20(18):2273-2293. PubMed ID: 31671001
    [No Abstract]   [Full Text] [Related]  

  • 10. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
    Herin DV; Rush CR; Grabowski J
    Ann N Y Acad Sci; 2010 Feb; 1187():76-100. PubMed ID: 20201847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
    Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
    Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological approaches to methamphetamine dependence: a focused review.
    Karila L; Weinstein A; Aubin HJ; Benyamina A; Reynaud M; Batki SL
    Br J Clin Pharmacol; 2010 Jun; 69(6):578-92. PubMed ID: 20565449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatments for methamphetamine addiction: current status and future directions.
    Ballester J; Valentine G; Sofuoglu M
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychostimulant treatment of cocaine dependence.
    Mariani JJ; Levin FR
    Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Stoops WW
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of stimulants to treat cocaine and methamphetamine abuse.
    Moeller FG; Schmitz JM; Herin D; Kjome KL
    Curr Psychiatry Rep; 2008 Oct; 10(5):385-91. PubMed ID: 18803911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sharafi H; Bakouni H; McAnulty C; Drouin S; Coronado-Montoya S; Bahremand A; Bach P; Ezard N; Le Foll B; Schütz CG; Siefried KJ; Tardelli VS; Ziegler D; Jutras-Aswad D
    Addiction; 2024 Feb; 119(2):211-224. PubMed ID: 37880829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.